HCC
STJ

Hirtle Callaghan & Co’s St Jude Medical STJ Stock Holding History

Hirtle Callaghan & Co’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,001
Closed -$65K – 455
2014
Q4 		$65K Hold
1,001
– – 0.02% 268
2014
Q3 		$60K Hold
1,001
– – 0.01% 288
2014
Q2 		$70K Hold
1,001
– – 0.01% 326
2014
Q1 		$66K Hold
1,001
– – 0.01% 320
2013
Q4 		$62K Hold
1,001
– – 0.01% 311
2013
Q3 		$54K Buy
+1,001
New +$51.6K 0.01% 330

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hirtle Callaghan & Co's STJ Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of St Jude Medical (STJ) in Q1 2015, closing a stake of 1,001 shares — an estimated $65K sold.

Hirtle Callaghan & Co first reported a position in STJ in Q3 2013 and held it in 6 quarters. The position peaked at $70K in Q2 2014. 590 funds tracked by Wall St. Rank hold STJ as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining St Jude Medical position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 1,001 St Jude Medical shares in Q1 2015, an estimated $65K.
  • Hirtle Callaghan & Co first reported a position in St Jude Medical in Q3 2013 and held it in 6 quarters.
  • Hirtle Callaghan & Co's St Jude Medical position peaked at $70K in Q2 2014.
  • 590 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.